Clear Cell Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Clear Cell Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-10Clinical Trial Update: Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC [Phase 2, Phase 3]
A Phase 2/3 trial evaluating Pylarify (piflufolastat F-18) PET/CT for suspected or high-risk metastatic clear cell renal cell carcinoma has …
-
CLINICAL_TRIALS withdrawal · 2025-11-12Clinical Trial Update: A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma [Phase 1, Phase 2]
This clinical trial update reports the termination of a Phase 1/2 study of NKT2152, a HIF2α inhibitor, in patients with advanced clear cell …
-
CLINICAL_TRIALS withdrawal · 2025-08-19Clinical Trial Update: PSMA Therapy and Immunotherapy in Kidney Cancer [Phase 1, Phase 2]
A clinical trial investigating PSMA-targeted therapy and immunotherapy for metastatic renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-06-18Clinical Trial Update: Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab [Phase 2]
An investigator-initiated Phase 2 trial evaluating the combination of ipilimumab, nivolumab, and stereotactic radiation for metastatic clear…
-
CLINICAL_TRIALS withdrawal · 2016-03-03Clinical Trial Update: A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer [NA]
This clinical trial (NCT02307474) evaluating SBRT with adjuvant pazopanib for renal cell carcinoma has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.